Replies to post #8826 on Capricor Therapeutics Inc (CAPR)

[XWAVXALMIMAN]

I listened to the entire conference call twice. I love the feature to listen at 1.5 or 2 times speed. I bought 7,000 more shares today. Linda Marban has a great plan. We will get to the 40 price target after FDA approval which is almost guaranteed. Sarepta is at 86 and was much higher with an inferior product. Kelliher who joined the board in September helped Horizon get bought out for 116.5 per share or $27.8 billion. Amgen which acquired Horizon is only 150 miles away from our headquarters. Could an FDA approval and Kelliher put us on the radar for a buyout by Amgen or other larger biotech companies? 2024 will be an exciting year for Capricor.